Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 252

    1.

    Meeting report: hazard assessment for nanoparticles--report from an interdisciplinary workshop.

    Balbus JM, Maynard AD, Colvin VL, Castranova V, Daston GP, Denison RA, Dreher KL, Goering PL, Goldberg AM, Kulinowski KM, Monteiro-Riviere NA, Oberdörster G, Omenn GS, Pinkerton KE, Ramos KS, Rest KM, Sass JB, Silbergeld EK, Wong BA.

    Environ Health Perspect. 2007 Nov;115(11):1654-9.PMID: 18007999 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.

    Warheit DB, Borm PJ, Hennes C, Lademann J.

    Inhal Toxicol. 2007 Jun;19(8):631-43.PMID: 17510836 [PubMed - indexed for MEDLINE]Related articles

    3.

    Ecotoxicity test methods and environmental hazard assessment for engineered nanoparticles.

    Crane M, Handy RD, Garrod J, Owen R.

    Ecotoxicology. 2008 Jul;17(5):421-37. Epub 2008 Apr 26.PMID: 18438709 [PubMed - indexed for MEDLINE]Related articles

    4.

    Nanotoxicology for safe and sustainable nanotechnology.

    Drobne D.

    Arh Hig Rada Toksikol. 2007 Dec;58(4):471-8. Review.PMID: 18063532 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

    EFSA GMO Panel Working Group on Animal Feeding Trials.

    Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Review.PMID: 18328408 [PubMed - indexed for MEDLINE]Related articles

    6.

    Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs.

    Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ, Thomas KV.

    Toxicol Sci. 2005 Nov;88(1):12-7. Epub 2005 Aug 24.PMID: 16120754 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.

    Bogdanffy MS, Daston G, Faustman EM, Kimmel CA, Kimmel GL, Seed J, Vu V.

    Toxicol Sci. 2001 May;61(1):18-31. Review.PMID: 11294970 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Databases applicable to quantitative hazard/risk assessment--towards a predictive systems toxicology.

    Waters M, Jackson M.

    Toxicol Appl Pharmacol. 2008 Nov 15;233(1):34-44. Epub 2008 Jul 2. Review.PMID: 18675838 [PubMed - indexed for MEDLINE]Related articles

    9.

    The Janus faces of nanoparticles.

    Donaldson K, Seaton A.

    J Nanosci Nanotechnol. 2007 Dec;7(12):4607-11.PMID: 18283852 [PubMed - indexed for MEDLINE]Related articles

    10.

    Resolving the nanoparticles paradox.

    Donaldson K.

    Nanomed. 2006 Aug;1(2):229-34. Review.PMID: 17716112 [PubMed - indexed for MEDLINE]Related articles

    11.

    Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions.

    Stone V, Johnston H, Clift MJ.

    IEEE Trans Nanobioscience. 2007 Dec;6(4):331-40. Review.PMID: 18217626 [PubMed - indexed for MEDLINE]Related articles

    12.

    Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles.

    Oberdörster G, Oberdörster E, Oberdörster J.

    Environ Health Perspect. 2005 Jul;113(7):823-39. Review.PMID: 16002369 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.

    Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB.

    Toxicol Sci. 2006 Jan;89(1):42-50. Epub 2005 Sep 21. Review.PMID: 16177233 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A 21st century paradigm for evaluating the health hazards of nanoscale materials?

    Walker NJ, Bucher JR.

    Toxicol Sci. 2009 Aug;110(2):251-4. Epub 2009 May 25.PMID: 19468057 [PubMed - indexed for MEDLINE]Related articles

    15.

    Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment.

    Blakey D, Galloway SM, Kirkland DJ, MacGregor JT.

    Mutat Res. 2008 Nov 17;657(1):84-90. Epub 2008 Sep 24.PMID: 18926925 [PubMed - indexed for MEDLINE]Related articles

    16.

    Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management.

    Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM.

    Toxicol Lett. 2007 Jul 10;171(3):99-110. Epub 2007 Apr 27.PMID: 17566673 [PubMed - indexed for MEDLINE]Related articles

    17.

    Drug delivery and nanoparticles:applications and hazards.

    De Jong WH, Borm PJ.

    Int J Nanomedicine. 2008;3(2):133-49. Review.PMID: 18686775 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Developmental immunotoxicology and risk assessment: a workshop summary.

    Holsapple MP.

    Hum Exp Toxicol. 2002 Sep-Oct;21(9-10):473-8.PMID: 12458903 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nanoparticles: pharmacological and toxicological significance.

    Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW.

    Br J Pharmacol. 2007 Mar;150(5):552-8. Epub 2007 Jan 22. Review.PMID: 17245366 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Naturally occurring asbestos: a recurring public policy challenge.

    Lee RJ, Strohmeier BR, Bunker KL, Van Orden DR.

    J Hazard Mater. 2008 May 1;153(1-2):1-21. Epub 2007 Nov 28. Review.PMID: 18180100 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data